Patent · US Active

Immunogenic peptide containing a b cell epitope of tumor associated antigen L6

US10995126B2 · kind B2 · utility

0Cited by
7References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 3, 2017
Grant dateMay 4, 2021
Priority date—
Expiry dateOct 5, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are an immunogenic peptide containing the sequence of CLDSLGQWN (SEQ ID NO:2) and a method of using the peptide for treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.